Faron Pharmaceuticals Oy
FPHAF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $282 | $217 | $242 | $230 |
| - Cash | $10 | $30 | $7 | $6 |
| + Debt | $12 | $13 | $13 | $13 |
| Enterprise Value | $285 | $199 | $249 | $237 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.173 | -0.173 | -0.184 | -0.155 |
| % Growth | 199.8% | 5.9% | -18.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |